Market competition is mounting to win the time, attention and interest of the most highly qualified clinical investigators. Field research shows that the most sought-after clinical investigation sites turn down 60 to 70 percent of the clinical trial invitations that they receive at their labs and clinics. Consequently, leading pharmaceutical companies must seek better ways to manage the art and science of investigator recruitment.
This recruitment challenge is two-pronged. First, clinical trial sponsors must find qualified investigators to participate in their studies. Second, they must screen qualified investigators to identify those who can provide sufficient numbers of suitable patients to meet a study’s timelines and protocol. Effective identification and development of clinical investigators and thought leaders is a cornerstone of the new product-development process. Companies that develop depth and skill in winning clinical investigators to their studies gain an advantage in bringing their products to market.
This toolkit integrates best practices in winning clinical investigators in a competitive marketplace into an easy-to-follow format. This toolkit is designed to aid managers in their efforts to identify, select and recruit top investigators in these therapeutic areas. The toolkit draws from interviews and surveys with executives at 15 pharmaceutical companies and 7 Contract Research Organizations/Site Management Organizations. It also includes insights gathered from interviews and surveys with a cross section of 20 investigators and investigative site staff members.
